Ce← Previous revisionRevision as of 18:10, 16 October 2026 Line 28: Line 28: [[File:John Bausch and Henry Lomb, New York State Men Biographic Studies and Character Portraits (1910).jpg|thumb|250px|John Bausch and Henry Lomb]] [[File:John Bausch and Henry Lomb, New York State Men Biographic Studies and Character Portraits (1910).jpg|thumb|250px|John Bausch and Henry Lomb]] '''Bausch & Lomb''' (since 2010 stylized as '''Bausch + Lomb''') is a Canadian eye health products company based in [[Vaughan]], Ontario. It produces [[contact lens|contact]]es and [[intraocular lens]]es, [[Medication|medications]], and [[eye surgery]]-related products.{{Cite web|last=Gorbman|first=Randy|title=Bausch + Lomb marks 50th anniversary of the soft contact lens|url=https://www.rochestercitynewspaper.com/rochester/bausch-lomb-marks-50th-anniversary-of-the-soft-contact-lens/Content?oid=12996961|access-date=2021-04-01|website=CITY News|language=en}}{{cite web |title=Contact Lenses Market Size, Share & Covid-19 Impact Analysis |url=https://www.fortunebusinessinsights.com/industry-reports/contact-lenses-market-101775 |publisher=Fortune Business Insights |access-date=28 May 2023 |date=April 2023}} '''Bausch & Lomb''' (stylized as '''Bausch + Lomb''' since 2010) is a Canadian eye health products company based in [[Vaughan]], Ontario. It produces [[contact lens|contacts]] and [[intraocular lens]]es, [[Medication|medications]], and [[eye surgery]]-related products.{{Cite web|last=Gorbman|first=Randy|title=Bausch + Lomb marks 50th anniversary of the soft contact lens|url=https://www.rochestercitynewspaper.com/rochester/bausch-lomb-marks-50th-anniversary-of-the-soft-contact-lens/Content?oid=12996961|access-date=2021-04-01|website=CITY News|language=en}}{{cite web |title=Contact Lenses Market Size, Share & Covid-19 Impact Analysis |url=https://www.fortunebusinessinsights.com/industry-reports/contact-lenses-market-101775 |publisher=Fortune Business Insights |access-date=28 May 2023 |date=April 2023}} Founded 1853 in [[Rochester, New York]] by optician [[John Jacob Bausch|John Bausch]] and financed by [[Henry Lomb]], it was one of the oldest continually operating companies in the United States;{{cite web|url=http://www.bausch.com/en_US/corporate/corpcomm/general/story.aspx |access-date=2007-04-19 |title=Bausch & Lomb: The Bausch + Lomb story |archive-url=https://web.archive.org/web/20070501210602/http://www.bausch.com/en_US/corporate/corpcomm/general/story.aspx |archive-date=1 May 2007 |url-status=dead }} it was [[Public company|publicly traded]] on [[New York Stock Exchange]], before being acquired by the [[private equity]] firm [[Warburg Pincus]] in 2007; the company was then sold to the Canadian company [[Bausch Health]] in 2013.{{cite web | url=https://www.latimes.com/business/la-xpm-2013-may-27-la-fi-mo-valeant-bausch-lomb-20130527-story.html | title=Valeant to buy contact-lens giant Bausch & Lomb for $4.5 billion | website=[[Los Angeles Times]] | date=27 May 2013 }}{{Cite news|url=https://www.bloomberg.com/news/articles/2013-05-27/valeant-agrees-to-buy-bausch-lomb-for-4-5-billion-cash|title=Valeant Agrees to Buy Bausch & Lomb in $8.7 Billion Deal|date=2013-05-28|work=Bloomberg.com|access-date=2017-03-14}} As of 2022, the company employs about 12,900 people. Founded 1853 in [[Rochester, New York]] by optician [[John Jacob Bausch|John Bausch]] and financed by [[Henry Lomb]], it was one of the oldest continually operating companies in the United States,{{cite web|url=http://www.bausch.com/en_US/corporate/corpcomm/general/story.aspx |access-date=2007-04-19 |title=Bausch & Lomb: The Bausch + Lomb story |archive-url=https://web.archive.org/web/20070501210602/http://www.bausch.com/en_US/corporate/corpcomm/general/story.aspx |archive-date=1 May 2007 |url-status=dead }} which was [[Public company|publicly traded]] on [[New York Stock Exchange]] before being acquired by the [[private equity]] firm [[Warburg Pincus]] in 2007. The company was then sold to the Canadian company [[Bausch Health]] in 2013.{{cite web | url=https://www.latimes.com/business/la-xpm-2013-may-27-la-fi-mo-valeant-bausch-lomb-20130527-story.html | title=Valeant to buy contact-lens giant Bausch & Lomb for $4.5 billion | website=[[Los Angeles Times]] | date=27 May 2013 }}{{Cite news|url=https://www.bloomberg.com/news/articles/2013-05-27/valeant-agrees-to-buy-bausch-lomb-for-4-5-billion-cash|title=Valeant Agrees to Buy Bausch & Lomb in $8.7 Billion Deal|date=2013-05-28|work=Bloomberg.com|access-date=2017-03-14}} As of 2022, the company employs about 12,900 people. ==History== ==History== {{Template:More citations needed section}} ===Early years=== ===Early years=== [[File:US-NY(1891) p639 ROCHESTER, THE BAUSCH & LOMB OPTICAL COMPANY.jpg|thumb|right|250px|New York headquarters of the Bausch & Lomb Optical Company in 1891]] [[File:US-NY(1891) p639 ROCHESTER, THE BAUSCH & LOMB OPTICAL COMPANY.jpg|thumb|right|250px|New York headquarters of the Bausch & Lomb Optical Company in 1891]] Line 143: Line 143: ==Operations== ==Operations== [[Image:Bausch & Lomb Vision Care campus.JPG|thumb|right|The Global Eye Health Center in [[Rochester, New York]]]] [[Image:Bausch & Lomb Vision Care campus.JPG|thumb|right|The Global Eye Health Center in [[Rochester, New York]]]] In the last few years, several business areas in the Vision Care division have been developed in the framework of product diversification. Vision care made $656 million during the first quarter of 2025, with revenua mainly coming from Daily SiHy lenses, Bausch + Lomb ULTRA®, over-the-counter [[dry eye]] products, LUMIFY, and eye vitamins.{{Cite web |date=2025-04-30 |title=Bausch + Lomb Announces First-Quarter 2025 Results |url=https://www.biospace.com/press-releases/bausch-lomb-announces-first-quarter-2025-results |access-date=2025-06-26 |website=BioSpace |language=en-US|archive-url=https://web.archive.org/web/20250724132146/https://www.biospace.com/press-releases/bausch-lomb-announces-first-quarter-2025-results|archive-date=2025-07-24}} Vision care made $656 million during the first quarter of 2025, with revenue mainly coming from Daily SiHy lenses, Bausch + Lomb ULTRA®, over-the-counter [[dry eye]] products, LUMIFY, and eye vitamins.{{Cite web |date=2025-04-30 |title=Bausch + Lomb Announces First-Quarter 2025 Results |url=https://www.biospace.com/press-releases/bausch-lomb-announces-first-quarter-2025-results |access-date=2025-06-26 |website=BioSpace |language=en-US|archive-url=https://web.archive.org/web/20250724132146/https://www.biospace.com/press-releases/bausch-lomb-announces-first-quarter-2025-results|archive-date=2025-07-24}} On July 2, 2004, the company announced that it had licensed the intellectual property of Novartis.{{cite news On July 2, 2004, the company announced that it had licensed the intellectual property of Novartis.{{cite news